Patients with hematologic malignancies sensitivity C-reactive protein test the significance of_0.doc

 PAGE \* MERGEFORMAT 8 Patients with hematologic malignancies sensitivity C-reactive protein test the significance of Of: Zhao Ying-bin, Lv Guihua, even Raymond LAI, Ding Yanling [Abstract] Objective To study the high sensitivity C-reactive protein (hs-CRP) in the blood system malignant diseases increased significance. Methods of acute leukemia, chronic leukemia, myelodysplastic syndrome (MDS), multiple myeloma (MM), metastatic cancer of bone marrow, aplastic anemia (AA) 6 Class hematologic malignancies for hs-CRP testing, various types of malignancies observed increase in the proportion of hs-CRP, hs-CRP will be all kinds of higher rates of hematologic malignancies and hs- CRP values #8203;#8203;compared with normal subjects. Results in 110 patients with hematologic malignancies increased in 98 cases (89.09%), higher rates of high to low as follows: bone marrow metastasis, AA, acute leukemia, chronic leukemia, MDS, MM. all kinds of hematologic malignancies hs-CRP values #8203;#8203;compared with the control group the difference was significant (P all lt;0.01). hs-CRP increased in various hematologic malignancies were higher than normal rate and the control group, hs-CRP can be used as blood disease screening indicators. [Keywords:] blood diseases, and high sensitive C-reactive protein C-reactive protein (CRP) is a classical acute phase protein, the body in inflammation and injury increased, the use of ultra-sensitivity CRP was detected by high sensitivity C-reactive protein as (hs-CRP), widely used in recent years, infection disease, cardiovascular disease diagnosis and monitoring. as acute phase protein, in hematologic malignancies, also should be a corresponding change, but very few of these reports, so we are in May 2006 ~ August 2008 I 110 cases of hospital patients for blood hs-CRP testing, the results reported below. 1 Materials and Methods 1.1 General Information The group, 110 patients were hospitalized in our hospital patients, 62